中国医科大学学报

中国医科大学学报

中国医科大学学报 ›› 2013, Vol. 42 ›› Issue (9): 841–844.

• 短篇论著 • 上一篇    下一篇

阿托伐他汀预防房颤电复律后复发的Meta分析

祁玉璟,张小卫,郭雪娅   

  1. 兰州大学第二医院心内科,兰州730030
  • 收稿日期:2013-04-26 出版日期:2013-09-18 发布日期:2013-11-26
  • 作者简介:祁玉璟(1987-),硕士研究生.
  • 基金资助:
    感谢兰州大学图书馆在文献的检索和全文获取过程中提供的帮助。

A Meta-analysis of Atorvastatin Preventing Recurrence for Patients after Atrial Fibrillation Electrical Cardioversion

  • Received:2013-04-26 Online:2013-09-18 Published:2013-11-26

摘要: 评价阿托伐他汀预防成功电复律后房颤复发的有效性和安全性。通过对纳入的4个RCTs进行系统的评价,提示阿托伐他汀能够降低成功电复律后3个月的房颤复发率,但对心血管不良事件的发生率无影响。

关键词: 心房颤动, 阿托伐他汀, 电复律, Meta分析

中图分类号: 

  • R541.7+5
[1] Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study [J]. JAMA, 2001, 285(18): 2370-2375.
[2] Stewart S, Hart CL, Hole DJ, et al. Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study [J]. Heart, 2001, 86(5): 516-521.
[3] Heeringa J, van der Kuip DA, Hofman A, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study [J]. Eur Heart J, 2006, 27(8): 949-953.
[4] Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence [J]. Circulation, 2006, 114(2): 119-125.
[5] Naccarelli GV, Varker H, Lin J, et al. Increasing prevalence of atrial fibrillation and flutter in the United States [J]. Am J Cardiol, 2009, 104(11): 1534-1539.
[6] Friberg L, Hammar N, Rosenqvist M. Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation [J]. Eur Heart J, 2010, 31(8): 967-975.
[7] Stewart S, Hart CL, Hole DJ, et al. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study [J]. Am J Med, 2002, 113(5): 359-364.
[8] Thrall G, Lane D, Carroll D, et al. Quality of life in patients with atrial fibrillation: a systematic review [J]. Am J Med, 2006, 119(5): 448 e1-19.
[9] Wann LS, Curtis AB, Ellenbogen KA, et al. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines [J]. J Am Coll Cardiol, 2011, 57(11): 1330-1337.
[10] Savelieva I, Kakouros N, Kourliouros A, et al. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention [J]. Europace, 2011, 13(3): 308-328.
[11] Savelieva I, Kakouros N, Kourliouros A, et al. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention [J]. Europace, 2011, 13(5): 610-625.
[12] Dentali F, Gianni M, Squizzato A, et al. Use of statins and recurrence of atrial fibrillation after catheter ablation or electrical cardioversion. A systematic review and meta-analysis [J]. Thromb Haemost, 2011, 106(2): 363-370.
[13] Fauchier L, Pierre B, de Labriolle A, et al. Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials [J]. J Am Coll Cardiol, 2008, 51(8): 828-835.
[14] http://handbook.cochrane.org/ .
[15] http://ims.cochrane.org/revman/download .
[16] Almroth H, Hoglund N, Boman K, et al. Atorvastatin and persistent atrial fibrillation following cardioversion: a randomized placebo-controlled multicentre study [J]. Eur Heart J, 2009, 30(7): 827-833.
[17] Demir K, Can I, Koc F, et al. Atorvastatin given prior to electrical cardioversion does not affect the recurrence of atrial fibrillation in patients with persistent atrial fibrillation who are on antiarrhythmic therapy [J]. Med Princ Pract, 2011, 20(5): 464-469.
[18] Negi S, Shukrullah I, Veledar E, et al. Statin therapy for the prevention of atrial fibrillation trial (SToP AF trial) [J]. J Cardiovasc Electrophysiol, 2011, 22(4): 414-419.
[19] Ozaydin M, Varol E, Aslan SM, et al. Effect of atorvastatin on the recurrence rates of atrial fibrillation after electrical cardioversion [J]. Am J Cardiol, 2006, 97(10): 1490-1493.
[1] 宋冲, 郑延琳, 兰晶, 花宇, 于波. 心房颤动患者冷冻球囊消融术后的护理体会[J]. 中国医科大学学报, 2018, 47(6): 569-571.
[2] 陆杰,李东玉,徐世安. 冠状动脉旁路移植术后新发心房颤动的多因素分析[J]. 中国医科大学学报, 2016, 45(3): 273-277.
[3] 魏芳, 闻庆平, 王春梅. 右美托咪啶对老年患者术后认知功能影响的Meta分析[J]. 中国医科大学学报, 2015, 44(9): 790-795.
[4] 滕巍,崔巍,刘沛. IL-28B基因多态性与HBeAg阳性的慢性乙型肝炎患者干扰素病毒学应答相关性的meta分析[J]. 中国医科大学学报, 2015, 44(8): 749-752.
[5] 陈建康,朱鹏立,严瑜,潘晓莉,杨津,林帆,林春锦. 小剂量利伐沙班对预防2型糖尿病伴心房颤动高龄患者脑卒中的疗效分析[J]. 中国医科大学学报, 2015, 44(8): 755-757.
[6] 张楚辞,赵玉岩,温晶. 利拉鲁肽与艾塞那肽治疗2型糖尿病降低体质量指标的meta分析[J]. 中国医科大学学报, 2015, 44(7): 591-595.
[7] 郭晓玉,李智,曲秀娟,刘云鹏. UGT1A1*6基因多态性与伊立替康毒性关系的meta分析[J]. 中国医科大学学报, 2015, 44(7): 596-601.
[8] 谷潇, 闫顺朝, 李午生, 赵力, 邹华伟. 热疗联合化疗治疗卵巢癌的Meta分析[J]. 中国医科大学学报, 2015, 44(6): 489-494.
[9] 苗鹏, 关琳, 邢承忠. 服用阿司匹林对结直肠癌患者生存获益的Meta分析与系统评价[J]. 中国医科大学学报, 2015, 44(6): 528-532.
[10] 王红岩,赵晓丹,李国胜,傅元,匡立润,崔仕健,刘峥嵘. 腹腔镜辅助与开腹胃癌D2根治术治疗局部进展期远端胃癌的安全性及近期疗效Meta分析[J]. 中国医科大学学报, 2015, 44(3): 252-258.
[11] 胡艳芬,,陈龙,荆超 ,,谢贤和. 流式细胞术检测DNA倍体数对鉴别良恶性肿瘤价值的Meta分析[J]. 中国医科大学学报, 2015, 44(2): 136-142.
[12] 王立国,李旭,李雷明,孟凡贺,王军,边磊,杜张诊,范广宇. 软组织修复预防后路初次全髋关节置换术后脱位的Meta分析[J]. 中国医科大学学报, 2014, 43(9): 842-845.
[13] 张秀春,赵传胜,刘咏梅. D?二聚体在颅内静脉窦血栓诊断中有效性的Meta分析[J]. 中国医科大学学报, 2014, 43(6): 502-512.
[14] 杜萍,常栋,陈畅. 阿托伐他汀对大鼠心肌缺血再灌注保护作用的实验研究[J]. 中国医科大学学报, 2014, 43(5): 407-410.
[15] 李挺松,肖增明,黄秋嫔,劳山,杨劲松,罗高斌. 降脂抗凝联合作用对兔激素性股骨头坏死骨细胞凋亡的影响[J]. 中国医科大学学报, 2014, 43(5): 441-445.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!

中国医科大学学报版权所有©2018

未经允许,严禁擅自转载本站图文资料

地址:中国 沈阳市沈北新区蒲河路77号 110122

辽ICP备05014850

JOURNAL OF CHINA MEDICAL UNIVERSITY

ADDRESS: NO.77 PUHE ROAD

SHENYANG NORTH NEW AREA, SHENYANG

LIAONING PROVINCE, P.R. CHINA